Last reviewed · How we verify

NCT07280039: MUSIC 2

Mortality and Muscle Mass Loss in Critically Ill Patients.

Not yet recruiting Last updated 12 December 2025
What this trial tests

trial in Mortality in 386 participants. Not yet recruiting.

Timeline
15 December 2025
Primary endpoint
15 December 2025
15 December 2026

Quick facts

Lead sponsorBrno University Hospital
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment386
Start date15 December 2025
Primary completion15 December 2025
Estimated completion15 December 2026
Sites1 location across Czechia

Conditions studied

Sponsor

Brno University Hospital

Who can join

18 and older, any sex, with Mortality or Muscle Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to monitor changes in muscle mass in critically ill patients and to verify whether a decrease in muscle mass of ≥10% during the first 7 days of hospitalization is associated with increased 28-day mortality. We will be used ultrasoud for measurement the rectus femoris cross sectional area.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Mortality

Currently open trials in the same condition.

Other Brno University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07280039.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing